Atlas Trials

Phase II Gemcitabine + Cisplatin +/- Iressa Bladder CCT

Clinical trial NCT00246974 · COMPLETED

Trial details

NCT number
NCT00246974
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Bladder Cancer
Start date
2003-05-01
Primary completion
2007-10-01
Enrollment
125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.